TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) is now available.
Zylox-Tonbridge Medical Technology Co., Ltd. has announced its 2024 Annual General Meeting (AGM) scheduled for May 30, 2025, in Hangzhou, China. The AGM will address several key resolutions, including the approval of the 2024 financial auditing report, profit distribution plan, and the re-appointment of PricewaterhouseCoopers as the external auditor for 2025. Additionally, the meeting will consider granting the Board general mandates to issue shares and repurchase H Shares, which could impact the company’s financial strategy and shareholder value.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the medical technology industry. The company focuses on developing and providing medical technology solutions, with a market presence in Hong Kong.
YTD Price Performance: 58.46%
Average Trading Volume: 256
Technical Sentiment Signal: Sell
Current Market Cap: €690.9M
Find detailed analytics on 2190 stock on TipRanks’ Stock Analysis page.